The analysis of another set of six genes, including MLH1 and BRCA1, with a previously established correlation between the methylation and expression status in borderline versus malignant tumors revealed that promoter methylation was associated with ovarian cancer risk and disease progression [128]. Here, BRCA1 is linked to ovarian cancer.